Sign in
Taking people in South KoreaNo phase

AI-guided personal diet plans for adults having a health check-up

Tests two kinds of AI diet guidance in adults at health screening.

Key facts

Who runs it
Seoul National University Hospital
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Agentic AI Personalized Dietary Management Study
Status
Recruiting
People taking part
200 people, planned
Started
11 Jun 2026
Expected to end
31 Dec 2028
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Static AI-based personalized dietary goal setting
  • Adaptive AI-based personalized dietary management
Record updated
15 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 20 or older who had a health check-up at the Seoul National University Hospital Gangnam Center and can use a smartphone on their own.

Age
20 Years to 90 Years
Sex
All sexes can join.
Earlier treatment
People who had weight-loss surgery or started a new anti-obesity drug in the past 3 months cannot join.

Main reasons for not taking part

  • Cannot use a smartphone or study apps or text messages
  • End-stage kidney disease or on dialysis
  • Active cancer or chemotherapy or radiotherapy
  • Pregnant or breastfeeding, or may become pregnant during the study
  • Weight-loss surgery or a newly started anti-obesity drug in the past 3 months

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Adults aged 20 years or older
  • Individuals from the general population who underwent a health examination at the Seoul National University Hospital Healthcare System Gangnam Center
  • Individuals who are capable of independently using a smartphone and operating study-related applications or text messaging functions
  • Individuals without conditions that significantly interfere with standard dietary management, as specified in the exclusion criteria [Section 9.2 Exclusion Criteria]

Who cannot take part

  • End-stage renal disease or patients currently receiving dialysis
  • Individuals with recent major weight-related interventions or extreme body weight changes within the past 3 months, including:Bariatric surgery such as gastrectomy or gastric bypass surgery Newly initiated anti-obesity pharmacotherapy (e.g., semaglutide/Wegovy, tirzepatide/Mounjaro)
  • Active cancer or currently undergoing chemotherapy or radiotherapy
  • Severe heart failure, liver cirrhosis, or hepatic insufficiency accompanied by varices, bleeding, ascites, hepatic encephalopathy, or jaundice
  • Malabsorption disorders such as Crohn's disease or short bowel syndrome
  • Diagnosed eating disorders or severe psychiatric disorders
  • Individuals unable to use a smartphone or study-related digital program/application, including those without a smartphone or unable to operate text messaging or application-based functions
  • Poorly controlled hyperthyroidism or hypothyroidism
  • Pregnant or breastfeeding women, or women who may become pregnant during study participation
  • Individuals considered by the investigator to have poor compliance potential or otherwise deemed unsuitable for participation in the clinical study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 90 years old?

Where in South Korea

  • Seoul National University Hospital Healthcare System Gangnam CenterSeoul, South KoreaContact: Su-Yeon Choi, PhDTaking people

About the trial

What the trial wants to find out

This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.

The 3 groups in the trial

  • Control groupNo study treatment, for comparison

    Participants receive standard dietary education and perform passive dietary recording during the 12-week study period.

  • Static goal AI intervention groupTreatment being tested

    Participants receive AI-generated personalized dietary goals that are maintained during the 12-week intervention period.

    Treatment: Static AI-based personalized dietary goal setting

  • Adaptive goal AI intervention groupTreatment being tested

    Participants receive adaptive AI-based dietary tracking, dynamic goal adjustment, and personalized feedback during the 12-week intervention period.

    Treatment: Adaptive AI-based personalized dietary management

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness of an Agentic AI-Based Personalized Dietary Management Algorithm in Health Screening Participants: A Randomized Controlled Trial
Plain-language title
AI-guided personal diet plans for adults having a health check-upGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07638241, who can take part
Record updated
15 September 2026